
Bispecific Antibodies and Cancer Immunotherapy

5 High-Throughput Screening Applications Using Flow Cytometry

Advanced Cancer Therapeutics: Increasing Efficacy and Specificity and Reducing Toxicity

Immune Surveillance in SARS-CoV-2 Vaccine Development

A 16-Color Flow Cytometry Panel to Monitor Checkpoint Inhibitor Expression and T-Cell Exhaustion Following Treatment with the PD1 Inhibitor Nivolumab
Presented by: Angie Green, PhD, Senior Scientist
View on demand
We discuss using a multiparameter flow cytometry panel to monitor T-cell exhaustion states and the expression of checkpoint inhibitors. We used an in vitro model; however, the panel is designed to be compatible with clinical samples to monitor immunotherapy.
